How will renaming PCOS to PMOS impact millions of women?

Polycystic Ovary Syndrome (PCOS), which impacts 1 in 8 women worldwide, is being renamed to Polyendocrine Metabolic Ovarian Syndrome (PMOS). Doctors believe this could help shift attention beyond fertility concerns and encourage earlier screening for diabetes, cardiovascular disease and mental health complications. It validates symptoms like fatigue and weight gain that were often dismissed.